Current application status and prospect of hybrid coronary revascularization_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

DING Tong , SHEN Liuzhong ,  HU Shengshou

Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P.R.China;

Corresponding author：

HU Shengshou, Email: shengshouhu@yahoo.com

Keywords：

Hybrid coronary revascularization; coronary artery bypass grafting; percutaneous coronary intervention

DOI：

10.7507/1007-4848.202005057

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Hybrid coronary revascularization (HCR) combining with coronary artery bypass grafting (CABG) has a long-term patency of left internal mammary artery to left anterior descending artery (LIMA-LAD) grafting, and the percutaneous coronary intervention (PCI) has a minimal invasiveness. It provides an alternative revascularization for patients with coronary heart disease. For patients who meet the HCR indications, most studies suggest that HCR can significantly reduce perioperative trauma, and offer favorable mid- and long-term prognosis, which is comparable with traditional revascularization strategies. Based on the major research results in this field in the past 10 years, we review the current application status and discuss the potential future direction of HCR in this paper.

Citation： DING Tong, SHEN Liuzhong, HU Shengshou. Current application status and prospect of hybrid coronary revascularization. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2021, 28(7): 863-869. doi: 10.7507/1007-4848.202005057 Copy

1.	Gaudino M, Antoniades C, Benedetto U, et al. Mechanisms, sonsequences, and prevention of coronary graft Failure. Circulation, 2017, 136(18): 1749-1764.
2.	Yamaji K, Räber L, Zanchin T, et al. Ten-year clinical outcomes of first-generation drug-eluting stents: The Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial. Eur Heart J, 2016, 37(45): 3386-3395.
3.	Ahmad Y, Howard JP, Arnold AD, et al. Mortality after drug-eluting stentsvs coronary artery bypass grafting for left main coronary artery disease: A meta-analysis of randomized controlled trials. Eur Heart J, 2020. [Epub ahead of print.
4.	Holm NR, Mäkikallio T, Lindsay MM, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: Updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet, 2020, 395(10219): 191-199.
5.	Angelini GD, Wilde P, Salerno TA, et al. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet, 1996, 347(9003): 757-758.
6.	Gao R, Hu S, Zheng Z, et al. "Hybrid" revascularization: video-thoracoscopy assisted MIDCAB combined with angioplasty. J Invasive Cardiol, 2001, 13(3): 257-259.
7.	Choi HJ, Kang J, Song H, et al. Comparison of coronary artery bypass graft-first and percutaneous coronary intervention-first approaches for 2-stage hybrid coronary revascularization. Korean J Thorac Cardiovasc Surg, 2017, 50(4): 247-254.
8.	Ganyukov V, Kochergin N, Shilov A, et al. Randomized clinical trial of surgicalvs. percutaneousvs. hybrid revascularization in multivessel coronary artery disease: Residual myocardial ischemia and clinical outcomes at one year-hybrid coronary revascularizationversus stenting or surgery (HREVS). J Interv Cardiol, 2020, 2020(5458064).
9.	Tajstra M, Hrapkowicz T, Hawranek M, et al. Hybrid coronary revascularization in selected patients with multivessel disease: 5-year clinical outcomes of the prospective randomized pilot study. JACC Cardiovasc Interv, 2018, 11(9): 847-852.
10.	Patel NC, Hemli JM, Kim MC, et al. Short- and intermediate-term outcomes of hybrid coronary revascularization for double-vessel disease. J Thorac Cardiovasc Surg, 2018, 156(5): 1799-1807.
11.	Wu S, Ling Y, Fu Y, et al. Mid-term follow-up outcomes of 2-staged hybrid coronary revascularization compared with off-pump coronary artery bypass for patients with multivessel coronary artery disease. Wideochir Inne Tech Maloinwazyjne, 2017, 12(2): 178-185.
12.	Rosenblum JM, Harskamp RE, Hoedemaker N, et al. Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts. J Thorac Cardiovasc Surg, 2016, 151(4): 1081-1089.
13.	Repossini A, Di Bacco L, Rosati F, et al. Hybrid coronary revascularization versus percutaneous strategies in left main stenosis: A propensity match study. J Cardiovasc Med (Hagerstown), 2018, 19(5): 253-260.
14.	Khaliel F, Giambruno V, Chu MWA, et al. Consequences of hybrid procedure addition to robotic-assisted direct coronary artery bypass. Innovations (Phila), 2017, 12(3): 192-196.
15.	Kiaii B, Teefy P. Hybrid coronary artery revascularization: A review and current evidence. Innovations (Phila), 2019, 14(5): 394-404.
16.	Hage A, Giambruno V, Jones P, et al. Hybrid coronary revascularizationversus off-pump coronary artery bypass grafting: Comparative effectiveness analysis with long-term follow-up. J Am Heart Assoc, 2019, 8(24): e014204.
17.	Giambruno V, Jones P, Khaliel F, et al. Hybrid coronary revascularization versus on-pump coronary artery bypass grafting. Ann Thorac Surg, 2018, 105(5): 1330-1335.
18.	Puskas JD, Halkos ME, DeRose JJ, et al. Hybrid coronary revascularization for the treatment of multivessel coronary artery disease: a multicenter observational study. J Am Coll Cardiol, 2016, 68(4): 356-365.
19.	Farid S, Ali JM, Stohlner V, et al. Long-term outcome of patients undergoing minimally invasive direct coronary artery bypass surgery: A single-center experience. Innovations (Phila), Jan/Feb 2018, 13(1): 23-28.
20.	Song Z, Shen L, Zheng Z, et al. One-stop hybrid coronary revascularization versus off-pump coronary artery bypass in patients with diabetes mellitus. J Thorac Cardiovasc Surg, 2016, 151(6): 1695-1701.
21.	Giambruno V, Hafiz A, Fox SA, et al. Is the future of coronary arterial revascularization a hybrid approach?: The Canadian experience across three centers. Innovations (Phila), Mar/Apr 2017, 12(2): 82-86.
22.	Xia Y, Katz AN, Forest SJ, et al. Hybrid coronary revascularization has improved short-term outcomes but worse mid-term reintervention rates compared to CABG: A propensity matched analysis. Innovations (Phila), 2017, 12(3): 174-179.
23.	Kitahara H, Hirai T, McCrorey M, et al. Hybrid coronary revascularization: Midterm outcomes of robotic multivessel bypass and percutaneous interventions. J Thorac Cardiovasc Surg, 2019, 157(5): 1829-1836.
24.	Singh T, Ayinapudi K, Motwani A, et al. A practical approach to hybrid coronary revascularization. Cardiol Rev, Sep/Oct 2020, 28(5): 240-243.
25.	Lowenstern A, Wu J, Bradley SM, et al. Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry. Am Heart J, 2019, 215: 167-177.
26.	宋涛, 张麒, 刘鸿昊, 等. 分站式Hybrid杂交手术治疗冠状动脉多支病变高龄患者的短期疗效分析. 中国胸心血管外科临床杂志, 2017, 24(10): 783-786.
27.	Shen L, Hu S, Wang H, et al. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution. J Am Coll Cardiol, 2013, 61(25): 2525-2533.
28.	Srivastava MC, Vesely MR, Lee JD, et al. Robotically assisted hybrid coronary revascularization: Does sequence of intervention matter? Innovations (Phila), 2013, 8(3): 177-183.
29.	Gao P, Xiong H, Zheng Z, et al. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization. Platelets, 2010, 21(3): 183-190.
30.	Meng M, Gao B, Wang X, et al. Long-term clinical outcomes of everolimus-eluting stentversus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: A meta-analysis. BMC Cardiovasc Disord, 2016, 16: 34.
31.	Panoulas VF, Colombo A, Margonato A, et al. Hybrid coronary revascularization: Promising, but yet to take off. J Am Coll Cardiol, 2015, 65(1): 85-97.
32.	韩雅玲. 中国经皮冠状动脉介入治疗指南(2016). 中华心血管病杂志, 2016, 44(5): 382-400.
33.	Hu SS, Xiong H, Zheng Z, et al. Midterm outcomes of simultaneous hybrid coronary artery revascularization for left main coronary artery disease. Heart Surg Forum, 2012, 15(1): E18-E22.
34.	Halkos ME, Rab ST, Vassiliades TA, et al. Hybrid coronary revascularizationversus off-pump coronary artery bypass for the treatment of left main coronary stenosis. Ann Thorac Surg, 2011, 92(6): 2155-2160.
35.	Zhou S, Fang Z, Xiong H, et al. Effect of one-stop hybrid coronary revascularization on postoperative renal function and bleeding: A comparison study with off-pump coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg, 2014, 147(5): 1511-1516.
36.	Harskamp RE, Walker PF, Alexander JH, et al. Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. Am Heart J, 2014, 168(4): 471-478.
37.	Zhu P, Zhou P, Sun Y, et al. Hybrid coronary revascularizationversus coronary artery bypass grafting for multivessel coronary artery disease: Systematic review and meta-analysis. J Cardiothorac Surg, 2015, 10: 63.
38.	Sardar P, Kundu A, Bischoff M, et al. Hybrid coronary revascularizationversus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis. Catheter Cardiovasc Interv, 2018, 91(2): 203-212.
39.	Saha T, Naqvi SY, Goldberg S. Hybrid revascularization: A review. Cardiology, 2018, 140(1): 35-44.
40.	Harskamp RE, Brennan JM, Xian Y, et al. Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: An analysis from the Society of Thoracic Surgeons Adult Cardiac Database. Circulation, 2014, 130(11): 872-879.
41.	Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for coronary artery bypass graft surgery: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2011, 124(23): e652-735.
42.	Kolh P, Windecker S, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg, 2014, 46(4): 517-592.

1. Gaudino M, Antoniades C, Benedetto U, et al. Mechanisms, sonsequences, and prevention of coronary graft Failure. Circulation, 2017, 136(18): 1749-1764.
2. Yamaji K, Räber L, Zanchin T, et al. Ten-year clinical outcomes of first-generation drug-eluting stents: The Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial. Eur Heart J, 2016, 37(45): 3386-3395.
3. Ahmad Y, Howard JP, Arnold AD, et al. Mortality after drug-eluting stentsvs coronary artery bypass grafting for left main coronary artery disease: A meta-analysis of randomized controlled trials. Eur Heart J, 2020. [Epub ahead of print.
4. Holm NR, Mäkikallio T, Lindsay MM, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: Updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet, 2020, 395(10219): 191-199.
5. Angelini GD, Wilde P, Salerno TA, et al. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet, 1996, 347(9003): 757-758.
6. Gao R, Hu S, Zheng Z, et al. "Hybrid" revascularization: video-thoracoscopy assisted MIDCAB combined with angioplasty. J Invasive Cardiol, 2001, 13(3): 257-259.
7. Choi HJ, Kang J, Song H, et al. Comparison of coronary artery bypass graft-first and percutaneous coronary intervention-first approaches for 2-stage hybrid coronary revascularization. Korean J Thorac Cardiovasc Surg, 2017, 50(4): 247-254.
8. Ganyukov V, Kochergin N, Shilov A, et al. Randomized clinical trial of surgicalvs. percutaneousvs. hybrid revascularization in multivessel coronary artery disease: Residual myocardial ischemia and clinical outcomes at one year-hybrid coronary revascularizationversus stenting or surgery (HREVS). J Interv Cardiol, 2020, 2020(5458064).
9. Tajstra M, Hrapkowicz T, Hawranek M, et al. Hybrid coronary revascularization in selected patients with multivessel disease: 5-year clinical outcomes of the prospective randomized pilot study. JACC Cardiovasc Interv, 2018, 11(9): 847-852.
10. Patel NC, Hemli JM, Kim MC, et al. Short- and intermediate-term outcomes of hybrid coronary revascularization for double-vessel disease. J Thorac Cardiovasc Surg, 2018, 156(5): 1799-1807.
11. Wu S, Ling Y, Fu Y, et al. Mid-term follow-up outcomes of 2-staged hybrid coronary revascularization compared with off-pump coronary artery bypass for patients with multivessel coronary artery disease. Wideochir Inne Tech Maloinwazyjne, 2017, 12(2): 178-185.
12. Rosenblum JM, Harskamp RE, Hoedemaker N, et al. Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts. J Thorac Cardiovasc Surg, 2016, 151(4): 1081-1089.
13. Repossini A, Di Bacco L, Rosati F, et al. Hybrid coronary revascularization versus percutaneous strategies in left main stenosis: A propensity match study. J Cardiovasc Med (Hagerstown), 2018, 19(5): 253-260.
14. Khaliel F, Giambruno V, Chu MWA, et al. Consequences of hybrid procedure addition to robotic-assisted direct coronary artery bypass. Innovations (Phila), 2017, 12(3): 192-196.
15. Kiaii B, Teefy P. Hybrid coronary artery revascularization: A review and current evidence. Innovations (Phila), 2019, 14(5): 394-404.
16. Hage A, Giambruno V, Jones P, et al. Hybrid coronary revascularizationversus off-pump coronary artery bypass grafting: Comparative effectiveness analysis with long-term follow-up. J Am Heart Assoc, 2019, 8(24): e014204.
17. Giambruno V, Jones P, Khaliel F, et al. Hybrid coronary revascularization versus on-pump coronary artery bypass grafting. Ann Thorac Surg, 2018, 105(5): 1330-1335.
18. Puskas JD, Halkos ME, DeRose JJ, et al. Hybrid coronary revascularization for the treatment of multivessel coronary artery disease: a multicenter observational study. J Am Coll Cardiol, 2016, 68(4): 356-365.
19. Farid S, Ali JM, Stohlner V, et al. Long-term outcome of patients undergoing minimally invasive direct coronary artery bypass surgery: A single-center experience. Innovations (Phila), Jan/Feb 2018, 13(1): 23-28.
20. Song Z, Shen L, Zheng Z, et al. One-stop hybrid coronary revascularization versus off-pump coronary artery bypass in patients with diabetes mellitus. J Thorac Cardiovasc Surg, 2016, 151(6): 1695-1701.
21. Giambruno V, Hafiz A, Fox SA, et al. Is the future of coronary arterial revascularization a hybrid approach?: The Canadian experience across three centers. Innovations (Phila), Mar/Apr 2017, 12(2): 82-86.
22. Xia Y, Katz AN, Forest SJ, et al. Hybrid coronary revascularization has improved short-term outcomes but worse mid-term reintervention rates compared to CABG: A propensity matched analysis. Innovations (Phila), 2017, 12(3): 174-179.
23. Kitahara H, Hirai T, McCrorey M, et al. Hybrid coronary revascularization: Midterm outcomes of robotic multivessel bypass and percutaneous interventions. J Thorac Cardiovasc Surg, 2019, 157(5): 1829-1836.
24. Singh T, Ayinapudi K, Motwani A, et al. A practical approach to hybrid coronary revascularization. Cardiol Rev, Sep/Oct 2020, 28(5): 240-243.
25. Lowenstern A, Wu J, Bradley SM, et al. Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry. Am Heart J, 2019, 215: 167-177.
26. 宋涛, 张麒, 刘鸿昊, 等. 分站式Hybrid杂交手术治疗冠状动脉多支病变高龄患者的短期疗效分析. 中国胸心血管外科临床杂志, 2017, 24(10): 783-786.
27. Shen L, Hu S, Wang H, et al. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution. J Am Coll Cardiol, 2013, 61(25): 2525-2533.
28. Srivastava MC, Vesely MR, Lee JD, et al. Robotically assisted hybrid coronary revascularization: Does sequence of intervention matter? Innovations (Phila), 2013, 8(3): 177-183.
29. Gao P, Xiong H, Zheng Z, et al. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization. Platelets, 2010, 21(3): 183-190.
30. Meng M, Gao B, Wang X, et al. Long-term clinical outcomes of everolimus-eluting stentversus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: A meta-analysis. BMC Cardiovasc Disord, 2016, 16: 34.
31. Panoulas VF, Colombo A, Margonato A, et al. Hybrid coronary revascularization: Promising, but yet to take off. J Am Coll Cardiol, 2015, 65(1): 85-97.
32. 韩雅玲. 中国经皮冠状动脉介入治疗指南(2016). 中华心血管病杂志, 2016, 44(5): 382-400.
33. Hu SS, Xiong H, Zheng Z, et al. Midterm outcomes of simultaneous hybrid coronary artery revascularization for left main coronary artery disease. Heart Surg Forum, 2012, 15(1): E18-E22.
34. Halkos ME, Rab ST, Vassiliades TA, et al. Hybrid coronary revascularizationversus off-pump coronary artery bypass for the treatment of left main coronary stenosis. Ann Thorac Surg, 2011, 92(6): 2155-2160.
35. Zhou S, Fang Z, Xiong H, et al. Effect of one-stop hybrid coronary revascularization on postoperative renal function and bleeding: A comparison study with off-pump coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg, 2014, 147(5): 1511-1516.
36. Harskamp RE, Walker PF, Alexander JH, et al. Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. Am Heart J, 2014, 168(4): 471-478.
37. Zhu P, Zhou P, Sun Y, et al. Hybrid coronary revascularizationversus coronary artery bypass grafting for multivessel coronary artery disease: Systematic review and meta-analysis. J Cardiothorac Surg, 2015, 10: 63.
38. Sardar P, Kundu A, Bischoff M, et al. Hybrid coronary revascularizationversus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis. Catheter Cardiovasc Interv, 2018, 91(2): 203-212.
39. Saha T, Naqvi SY, Goldberg S. Hybrid revascularization: A review. Cardiology, 2018, 140(1): 35-44.
40. Harskamp RE, Brennan JM, Xian Y, et al. Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: An analysis from the Society of Thoracic Surgeons Adult Cardiac Database. Circulation, 2014, 130(11): 872-879.
41. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for coronary artery bypass graft surgery: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2011, 124(23): e652-735.
42. Kolh P, Windecker S, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg, 2014, 46(4): 517-592.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Current application status and prospect of hybrid coronary revascularization

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content